Epithalon
One of the few 'longevity peptides' with actual elderly-cohort human trial data behind it. From a specific, not-widely-replicated Russian research program.
What is Epithalon?
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide, sequence Ala-Glu-Asp-Gly, built as a simplified version of epithalamin, an extract of the pineal gland. It came out of decades of Russian aging research led by Vladimir Khavinson, and it is one of the longest-studied compounds in the longevity-peptide world. It is not FDA-approved, and the honest picture is a mix of genuinely interesting cell-biology findings and human claims that outrun the evidence.
How Epithalon works
The headline mechanism is telomerase activation. In human cell cultures, Epithalon can switch on telomerase (the enzyme that rebuilds the protective caps on your chromosomes) and lengthen telomeres. It is also proposed to support pineal function and melatonin rhythms. The important nuance is that switching on telomerase in a dish is not the same as reversing aging in a person, and most of the mechanism work sits at the cell and animal level.
What the research shows
Epithalon's telomerase and telomere-lengthening effect in human somatic cell cultures is real and has been independently reproduced, most recently in a 2025 replication. Khavinson's group has also reported human studies suggesting effects on health and mortality markers in elderly cohorts. The limitation is scope and independence: no completed, controlled human trial has measured telomere length before and after Epithalon in living people, and the strongest results trace back to one research tradition rather than broad replication.
Dosage and how it is used
There is no approved dose. The Russian research protocols used short cyclical courses, often 10 to 20 days, repeated periodically rather than taken continuously. Community protocols copy that pattern, but the specific numbers are not backed by modern dose-finding trials.
→ How to reconstitute Epithalon: calculator, units to draw & storage
Side effects and safety
Epithalon has generally been reported as well tolerated in the studies available, with no major safety alarms at the doses used, and it has one of the longer real-world histories in this space. That said, long-term safety data outside those Russian studies is limited, telomerase activation carries a theoretical concern given the role of telomerase in cancer biology, and it has never passed Western regulatory review.
- Long research history, but strongest results from a single group and not broadly replicated.
- In-vitro telomerase effect is real; human in-vivo telomere data is essentially absent.
- Not FDA-approved. Theoretical caution given telomerase's role in cancer. Verify status independently.
Frequently asked questions
Does Epithalon actually lengthen telomeres?
In cell cultures it activates telomerase and can elongate telomeres, and that in-vitro effect has been independently replicated. Whether it does the same in living human tissue has not been established in a controlled trial, so the human longevity claims remain unproven.
Who studied Epithalon?
Most of the research comes from Vladimir Khavinson's group in St. Petersburg, including long-running work on pineal peptides and some elderly-cohort studies. The strongest results come from that single research tradition and have not been widely replicated at scale in the West.
How is Epithalon dosed?
Russian research used short cyclical courses, for example 10 to 20 days, rather than continuous daily use. There is no FDA-approved dose, and self-use figures are convention rather than validated medicine.
Is Epithalon FDA-approved?
No. It is not approved for any human use in the US. It is a research compound, and its legal status varies by jurisdiction.
References
Track Epithalon in Peptide AI
Log your doses, connect labs and wearables, and let the AI show you how Epithalon is affecting your biomarkers over time.
Download the appEducational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.